INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2014
Net Assets |
£208m |
Net Assets per share |
491p |
Share price |
443p |
Total value of unquoted investments |
£21m |
Total number of portfolio companies |
81 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
8.5 |
Gilead |
6.8 |
Biogen-Idec |
6.4 |
Chimerix |
5.4 |
Alexion |
4.7 |
Vertex |
4.6 |
Amgen |
4.5 |
Regeneron |
3.4 |
Pharmacyclics |
2.8 |
Ophthotech |
2.5 |
|
----------- |
Total |
49.6 |
Portfolio Profitability |
% NAV |
Profitable |
57 |
Turning Profitable 2015 |
7 |
Unprofitable |
36 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
89 |
Europe & UK |
11 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 JANUARY 2015